Biotoxtech Co. Ltd
Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and b… Read more
Biotoxtech Co. Ltd (086040) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.010x
Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has a cash flow conversion efficiency ratio of -0.010x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-354.72 Million) by net assets (₩34.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biotoxtech Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Biotoxtech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biotoxtech Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotoxtech Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Erdene Resource Development Corporation
PINK:ERDCF
|
-0.018x |
|
Shougang Concord Grand (Group) Limited
F:CGG
|
-0.003x |
|
Vikas Lifecare Limited
NSE:VIKASLIFE
|
0.003x |
|
Louisa Professional Coffee Ltd
TWO:2758
|
0.151x |
|
PermRock Royalty Trust
NYSE:PRT
|
-0.010x |
|
Space Hellas SA
AT:SPACE
|
-0.583x |
|
EVERFUEL A/S DK -10
F:0HR
|
N/A |
|
Camus Engineering & Construction Inc
KO:013700
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Biotoxtech Co. Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Biotoxtech Co. Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩40.08 Billion | ₩-7.12 Billion | -0.178x | +47.23% |
| 2023-12-31 | ₩48.23 Billion | ₩-16.24 Billion | -0.337x | -1037.55% |
| 2022-12-31 | ₩44.23 Billion | ₩-1.31 Billion | -0.030x | -128.02% |
| 2021-12-31 | ₩41.14 Billion | ₩4.35 Billion | 0.106x | -22.40% |
| 2020-12-31 | ₩33.53 Billion | ₩4.56 Billion | 0.136x | +184.65% |
| 2019-12-31 | ₩30.19 Billion | ₩1.44 Billion | 0.048x | -51.17% |
| 2018-12-31 | ₩31.25 Billion | ₩3.06 Billion | 0.098x | -56.77% |
| 2017-12-31 | ₩26.59 Billion | ₩6.02 Billion | 0.227x | +5.24% |
| 2016-12-31 | ₩24.54 Billion | ₩5.28 Billion | 0.215x | +736.12% |
| 2015-12-31 | ₩23.58 Billion | ₩-798.17 Million | -0.034x | +55.89% |
| 2014-12-31 | ₩26.68 Billion | ₩-2.05 Billion | -0.077x | -221.95% |
| 2012-12-31 | ₩25.93 Billion | ₩1.63 Billion | 0.063x | -58.32% |
| 2011-12-31 | ₩21.74 Billion | ₩3.28 Billion | 0.151x | -- |